The North America Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 19.6% CAGR during the forecast period (2021-2027).
Automated process system as a sustainable strategy to boost their cell therapy product development procedure, which would propel the growth of the market. There has been an increase in clinical trials regarding advanced therapies in the past few years, which is estimated to surge the demand for advanced & automated technologies to get high yield and throughput.
The strong healthcare sector of developed nations like the US and Canada is estimated to support the growth of the regional market. In addition, the high adoption of various advanced systems, therapies, and solutions in the regional healthcare sector is estimated to support the growth of the regional automated and closed cell therapy processing system market in the upcoming years. Along with that, the growing popularity of regenerative medicines and stem cell therapies would accelerate the growth of the regional market over the forecast period.
The US market dominated the North America Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $709.8 million by 2027. The Canada market is estimated to grow a CAGR of 22.3% during (2021 - 2027). Additionally, The Mexico market would showcase a CAGR of 21.2% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Automated and Closed Cell Therapy Processing Systems Market is Estimated to reach $37.9 billion by 2027, at a CAGR of 32.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Separation
- Expansion
- Apheresis
- Fill-Finish
- Cryopreservation
By Workflow
- Stem Cell Therapy
- Non-Stem Cell Therapy
By Scale
- Pre-commercial/R&D Scale
- Commercial Scale
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Automated And Closed Cell Therapy Processing Systems Market, by workflow
1.4.2 North America Automated And Closed Cell Therapy Processing Systems Market, by type
1.4.3 North America Automated And Closed Cell Therapy Processing Systems Market, by Scale
1.4.4 North America Automated And Closed Cell Therapy Processing Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
Chapter 4. North America Automated and Closed Cell Therapy Processing Systems Market by Type
4.1 North America Non-Stem Cell Therapy Market by Country
4.2 North America Stem Cell Therapy Market by Country
Chapter 5. North America Automated and Closed Cell Therapy Processing Systems Market by Workflow
5.1 North America Expansion Market by Country
5.2 North America Separation Market by Country
5.3 North America Apheresis Market by Country
5.4 North America Cryopreservation Market by Country
5.5 North America Fill- Finish Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Automated and Closed Cell Therapy Processing Systems Market by Scale
6.1 North America Pre-commercial/ R&D Scale Market by Country
6.2 North America Commercial Scale Market by Country
Chapter 7. North America Automated and Closed Cell Therapy Processing Systems Market by Country
7.1 US Automated and Closed Cell Therapy Processing Systems Market
7.1.1 US Automated and Closed Cell Therapy Processing Systems Market by Type
7.1.2 US Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.1.3 US Automated and Closed Cell Therapy Processing Systems Market by Scale
7.2 Canada Automated and Closed Cell Therapy Processing Systems Market
7.2.1 Canada Automated and Closed Cell Therapy Processing Systems Market by Type
7.2.2 Canada Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.2.3 Canada Automated and Closed Cell Therapy Processing Systems Market by Scale
7.3 Mexico Automated and Closed Cell Therapy Processing Systems Market
7.3.1 Mexico Automated and Closed Cell Therapy Processing Systems Market by Type
7.3.2 Mexico Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.3.3 Mexico Automated and Closed Cell Therapy Processing Systems Market by Scale
7.4 Rest of North America Automated and Closed Cell Therapy Processing Systems Market
7.4.1 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Type
7.4.2 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Workflow
7.4.3 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Scale
Chapter 8. Company Profiles
8.1 Lonza Group AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 Terumo Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Cytiva (Danaher Corporation)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Miltenyi Biotech B.V. & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Product Launches and Product Expansions:
8.5.2.3 Acquisition and Mergers:
8.6 ThermoGenesis Holdings, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Cellares, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Biospherix ltd.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Sartorius AG
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.1 Fresenius SE & Co. KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Acquisition and Mergers:
TABLE 1 North America Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 2 North America Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Automated And Closed Cell Therapy Processing Systems Market
TABLE 4 Product Launches And Product Expansions– Automated And Closed Cell Therapy Processing Systems Market
TABLE 5 Acquisition and Mergers– Automated And Closed Cell Therapy Processing Systems Market
TABLE 6 North America Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 7 North America Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 8 North America Non-Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Non-Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Stem Cell Therapy Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Stem Cell Therapy Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 13 North America Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 14 North America Expansion Market by Country, 2017 - 2020, USD Million
TABLE 15 North America Expansion Market by Country, 2021 - 2027, USD Million
TABLE 16 North America Separation Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Separation Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Apheresis Market by Country, 2017 - 2020, USD Million
TABLE 19 North America Apheresis Market by Country, 2021 - 2027, USD Million
TABLE 20 North America Cryopreservation Market by Country, 2017 - 2020, USD Million
TABLE 21 North America Cryopreservation Market by Country, 2021 - 2027, USD Million
TABLE 22 North America Fill- Finish Market by Country, 2017 - 2020, USD Million
TABLE 23 North America Fill- Finish Market by Country, 2021 - 2027, USD Million
TABLE 24 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 25 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 26 North America Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 27 North America Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 28 North America Pre-commercial/ R&D Scale Market by Country, 2017 - 2020, USD Million
TABLE 29 North America Pre-commercial/ R&D Scale Market by Country, 2021 - 2027, USD Million
TABLE 30 North America Commercial Scale Market by Country, 2017 - 2020, USD Million
TABLE 31 North America Commercial Scale Market by Country, 2021 - 2027, USD Million
TABLE 32 North America Automated and Closed Cell Therapy Processing Systems Market by Country, 2017 - 2020, USD Million
TABLE 33 North America Automated and Closed Cell Therapy Processing Systems Market by Country, 2021 - 2027, USD Million
TABLE 34 US Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 35 US Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 36 US Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 37 US Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 38 US Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 39 US Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 40 US Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 41 US Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 42 Canada Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 43 Canada Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 44 Canada Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 45 Canada Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 46 Canada Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 47 Canada Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 48 Canada Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 49 Canada Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 50 Mexico Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 51 Mexico Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 52 Mexico Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 53 Mexico Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 54 Mexico Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 55 Mexico Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 56 Mexico Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 57 Mexico Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 58 Rest of North America Automated and Closed Cell Therapy Processing Systems Market, 2017 - 2020, USD Million
TABLE 59 Rest of North America Automated and Closed Cell Therapy Processing Systems Market, 2021 - 2027, USD Million
TABLE 60 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Type, 2017 - 2020, USD Million
TABLE 61 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Type, 2021 - 2027, USD Million
TABLE 62 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2017 - 2020, USD Million
TABLE 63 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Workflow, 2021 - 2027, USD Million
TABLE 64 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Scale, 2017 - 2020, USD Million
TABLE 65 Rest of North America Automated and Closed Cell Therapy Processing Systems Market by Scale, 2021 - 2027, USD Million
TABLE 66 Key Information – Lonza Group AG
TABLE 67 Key Information – Terumo Corporation
TABLE 68 Key Information – Cytiva
TABLE 69 Key Information – Thermo Fisher Scientific, Inc.
TABLE 70 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 71 Key information – THERMOGENESIS HOLDINGS, INC.
TABLE 72 Key information – Cellares, Inc.
TABLE 73 Key information – Biospherix ltd.
TABLE 74 Key Information – Sartorius AG
TABLE 75 key information – Fresenius SE & Co. KGaA
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2018, Feb – 2021, Oct) Leading Players
FIG 5 Recent strategies and developments: Lonza Group AG
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Miltenyi Biotec B.V. & Co. KG
FIG 8 Recent strategies and developments: Sartorius AG